The drugs PAB make seem to work.
Just cant make the drugs yet after many, many years and many, many shareholder dollars.
I'm sure if they have a manufacture breakthrough, so will the share price.
My gut feeling is they cant mass produce IgM antibodies at scale consistently.
This is the reason to move into CAR-T cells and a sp. below 2 cents.
Ann: Patrys 2014 AGM Presentation, page-26
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
-0.002(33.3%) |
Mkt cap ! $8.229M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $95.25K | 26.45M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 52 | 29109964 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 19424458 | 8 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| PAB (ASX) Chart |